Repare Therapeutics DSO Ratio 2011-2026 | RPTX

Annual DSO Ratio Repare Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	16.7 K	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
16.7 K	16.7 K	16.7 K

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	2.94 K	-	5743.5 %	$ 69.7 M	Canada
Coherus BioSciences CHRS	559	$ 1.57	-3.68 %	$ 184 M	USA
Happiness Biotech Group Limited HAPP	29	-	1.35 %	$ 17.8 M	China
Amphastar Pharmaceuticals AMPH	70.9	$ 16.87	-2.49 %	$ 789 M	USA
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Arcturus Therapeutics Holdings ARCT	21.2	$ 7.47	-4.6 %	$ 205 M	Israel
Eton Pharmaceuticals ETON	39.1	$ 30.26	1.0 %	$ 814 M	USA
Exelixis EXEL	43.4	$ 50.13	-1.9 %	$ 13.6 B	USA
Fortress Biotech FBIO	115	$ 2.41	4.78 %	$ 67.2 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
AbCellera Biologics ABCL	173	$ 4.09	-7.05 %	$ 1.22 B	Canada
Autolus Therapeutics plc AUTL	58.2	$ 1.63	2.52 %	$ 434 M	Britain
Celyad Oncology SA CYAD	64.4	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	47.6	-	-	$ 344 M	USA
IMV IMV	2.16 K	-	-	$ 13.1 M	Canada
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Gilead Sciences GILD	57.8	$ 129.58	-1.88 %	$ 161 B	USA
Advaxis ADXS	3.28 K	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 3.36	-3.72 %	$ 5.53 M	Israel
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	126	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Esperion Therapeutics ESPR	99.7	$ 3.12	-	$ 649 M	USA
Genmab A/S GMAB	97.9	$ 26.54	-1.34 %	$ 1.72 B	Danmark
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA